27 Sep 2022
Revascularisation for Ischemic heart failure: is PCI as good as CABG?
The surgeon's perspective versus the interventional cardiologist's perspective: the REVIVED trial
Summary
Pamela Gatto interviews Volkmar Falk, Cardiovascular Surgeon, and Dejan Milasinovic, Interventional Cardiologist, to get their perspective about the results of the REVIVED-BCIS2 trial.
The 3 questions are:
- What were your first thoughts and feelings when the findings from REVIVED were presented at ESC 2022?
- In STICH(es), CABG had a mortality benefit over medical treatment. No such benefit of PCI vs. MT in REVIVED BCIS2. Does that mean that CABG is superior to PCI in ischemic cardiomyopathy? How do you interpret these results?
- Which is your take on REVIVED BCIS2?